• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A clinical study of 130 patients with biliary tract cancers and periampullary tumors.

作者信息

Su W C, Chan K K, Lin X Z, Lin P W, Chow N H, Shin J S, Chen C Y, Tsao C J

机构信息

Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, ROC.

出版信息

Oncology. 1996 Nov-Dec;53(6):488-93. doi: 10.1159/000227625.

DOI:10.1159/000227625
PMID:8960145
Abstract

A retrospective review of 130 patients with peripheral-type cholangiocarcinomas (PTCC), hilar-type cholangiocarcinomas (HTCC), extrahepatic cholangiocarcinomas (EHCC), gallbladder cancers (GBCA), and periampullary cancers (PACA), seen at National Cheng Kung University Hospital and Tainan Municipal Hospital from June 1987 to July 1993 was performed. There were 47 (36%) HTCC, 32 (25%) PACA, 24 (19%) PTCC, 17 (13%) GBCA, and 10 (8%) EHCC patients. The distribution is completely different from that reported in western countries. These cancers mainly occur in elderly patients. HTCC and GBCA were predominantly noted in female patients. Biliary cancers in Taiwan were not related to liver fluke infestation, inflammatory bowel disease or hepatitis B virus infection. However, a close association with biliary lithiasis was found. The incidence of gallstones was 67, 39, 20, 29 and 19% for PTCC, HTCC, EHCC, GBCA and PACA, respectively. The most common presentation for PTCC and GBCA was abdominal pain, or jaundice for HTCC, EHCC and PACA. These symptoms correlate well with the location of the tumors. Among serum tumor markers, the elevation of CA19-9 was most frequent, occurring in 86% of the patients while CA125 and CEA occurred in 47% and 30% of the patients, respectively. During the course of disease, infection developed in 61% of the patients and was the main cause of death in 25%. Biliary tract infection and sepsis were the two leading manifestations and occurred in 49% and 32% of the patients, respectively. Overall survival was poor except in patients whose tumor could be completely resected.

摘要

相似文献

1
A clinical study of 130 patients with biliary tract cancers and periampullary tumors.
Oncology. 1996 Nov-Dec;53(6):488-93. doi: 10.1159/000227625.
2
[Clinical, epidemiological and therapeutic features of biliary tract cancers: about 20 cases].胆管癌的临床、流行病学及治疗特征:约20例报告
Pan Afr Med J. 2018 Jan 4;29:13. doi: 10.11604/pamj.2018.29.13.9922. eCollection 2018.
3
Multiple tumors of the biliary tract.胆道多发性肿瘤
Am J Surg. 1990 Apr;159(4):386-8. doi: 10.1016/s0002-9610(05)81278-4.
4
Malignancies of the biliary tree.胆道恶性肿瘤
Curr Probl Surg. 1995 Jan;32(1):1-90. doi: 10.1016/s0011-3840(05)80011-5.
5
Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.血清CYFRA 21-1在胆道癌中的作用:胆囊癌和肝内胆管癌的可靠生物标志物
Dig Dis Sci. 2015 May;60(5):1273-83. doi: 10.1007/s10620-014-3472-0. Epub 2014 Dec 9.
6
Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study.男性肝外胆管癌的危险因素:健康状况与生活方式:一项欧洲多中心病例对照研究的结果
Eur J Gastroenterol Hepatol. 2007 Aug;19(8):623-30. doi: 10.1097/01.meg.0000243876.79325.a1.
7
Biliary tract cancers in Cote-d'Or (France): incidence and natural history.法国科多尔省的胆道癌:发病率与自然病史
J Epidemiol Community Health. 1987 Dec;41(4):344-8. doi: 10.1136/jech.41.4.344.
8
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.
9
Time to move to targeted drugs in biliary tract cancer?是时候转向治疗胆管癌的靶向药物了吗?
Onkologie. 2010;33(1-2):10-1. doi: 10.1159/000271544. Epub 2010 Jan 22.
10
Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.胰十二指肠切除术切除的胰腺癌、壶腹癌、胆管癌和十二指肠癌的分布及病理特征
World J Surg Oncol. 2015 Feb 28;13:85. doi: 10.1186/s12957-015-0498-5.

引用本文的文献

1
Epidemiology, survival and new treatment modalities for intrahepatic cholangiocarcinoma.肝内胆管癌的流行病学、生存率及新治疗方式
J Gastrointest Oncol. 2024 Aug 31;15(4):1777-1788. doi: 10.21037/jgo-24-165. Epub 2024 Aug 28.
2
Epidemiology of primary and secondary liver cancers.原发性和继发性肝癌的流行病学
Semin Intervent Radiol. 2006 Mar;23(1):47-63. doi: 10.1055/s-2006-939841.
3
Mesothelin as a potential therapeutic target in human cholangiocarcinoma.间皮素作为人类胆管癌的潜在治疗靶点。
J Cancer. 2010 Oct 1;1:141-9. doi: 10.7150/jca.1.141.
4
Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.未经手术、化疗或放疗的晚期胆管癌的自然史和预后因素:一项大规模观察性研究。
Gut Liver. 2009 Dec;3(4):298-305. doi: 10.5009/gnl.2009.3.4.298. Epub 2009 Dec 31.
5
Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.血清CA19-9在胆管癌诊断中的应用:与癌胚抗原的比较。
World J Gastroenterol. 2004 Feb 1;10(3):427-32. doi: 10.3748/wjg.v10.i3.427.
6
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer.血清细胞角蛋白19片段(CYFRA 21-1)作为原发性肝癌的标志物
Br J Cancer. 2003 Jun 16;88(12):1894-9. doi: 10.1038/sj.bjc.6601026.
7
Cholecystectomy, liver resection, and pylorus-preserving pancreaticoduodenectomy for gallbladder cancer: report of five cases.胆囊癌的胆囊切除术、肝切除术和保留幽门的胰十二指肠切除术:5例报告
J Gastrointest Surg. 2002 Sep-Oct;6(5):776-80. doi: 10.1016/s1091-255x(02)00039-2.
8
Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.致癌基因产物HER2/Neu和Ras以及纤维化相关生长因子bFGF、TGF-β和PDGF在胆道恶性肿瘤和炎症性疾病胆汁中的表达。
Dig Dis Sci. 2001 Jul;46(7):1387-92. doi: 10.1023/a:1010619316436.